Please login to the form below

Not currently logged in
Email:
Password:

peginterferon beta-1a

This page shows the latest peginterferon beta-1a news and features for those working in and with pharma, biotech and healthcare.

Biogen and AbbVie bag FDA approval for multiple sclerosis drug

Biogen and AbbVie bag FDA approval for multiple sclerosis drug

patients by 45% when compared with Avonex (peginterferon beta-1a) at week 144. ... The new approval adds to Biogen's already sizeable stable of MS drugs on the market, which include Avonex and its long-acting version Plegridy (peginterferon beta-1a), and

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics